Colorado Might Finally Force Insurers to Stop Pushing Opioids First

The Bottom Line

If you need pain medication but want to avoid opioids, your insurance company can no longer make it harder or more expensive to get a non-opioid alternative. This legislation forces health plans to level the playing field by capping your copays and stripping away insurance red tape for non-opioid painkillers.

What This Bill Actually Does

Right now, the healthcare system has a frustrating economic quirk: insurance companies often make it incredibly cheap and easy to get a prescription for highly addictive opioids, while throwing up massive roadblocks for safer, non-opioid alternatives. This legislation tackles that discrepancy head-on by mandating insurance parity. If a doctor prescribes an FDA-approved non-opioid drug for the treatment or management of chronic or acute pain, your state-regulated health insurance plan must cover it just as seamlessly as they would an opioid.

Specifically, the bill targets out-of-pocket costs and administrative hurdles. It dictates that your cost-sharing, copayments, or deductibles for non-opioid pain management drugs cannot be a single cent higher than what you'd pay for an opioid. Insurers are also required to ensure that there is at least one clinically appropriate non-opioid prescription alternative available on their formulary for every opioid prescription drug they cover.

Finally, the legislation takes aim at utilization review requirements, which is industry jargon for the hoops patients and doctors must jump through to get a treatment covered. Under this law, insurers cannot use prior authorizations (requiring special permission before filling a script) or step therapy (forcing you to fail on a cheaper drug before covering the one your doctor actually ordered) for non-opioids if they don't require the exact same hurdles for opioids. This sweeping rule applies to private insurance carriers regulated by the state, as well as the state's Medicaid program managed by the Department of Health Care Policy and Financing.

What It Means for You

If you are dealing with an injury, recovering from surgery, or managing a stubborn chronic pain condition, this legislation fundamentally changes your options at the pharmacy counter. Historically, many Coloradans have walked out of the hospital with a bottle of opioids simply because their insurance wouldn't cover the non-addictive alternative, or because the non-opioid required days of back-and-forth approval paperwork while they were actively in pain. Going forward, the choice between an opioid and a non-opioid will be driven by what is medically best for you, not what happens to be cheapest for your health plan.

Practically speaking, you should expect to see lower out-of-pocket costs for non-opioid pain medications once insurers update their policies for the upcoming plan years. If your plan charges a standard $10 copay for generic Vicodin, they can no longer charge you $50 for a targeted non-opioid alternative. Just as importantly, you won't have to wait for your doctor to fight with your insurance company over a prior authorization just to get you a safer medication. Whether you are dealing with acute pain (like a broken bone or dental surgery) or chronic pain (like long-term back issues), the rules apply the same.

Keep an eye on your health plan's prescription drug formulary during your next open enrollment. Because insurers are now mandated to offer at least one non-opioid alternative for every opioid they cover, you will want to check which specific non-opioid medications made the approved list for your particular condition. One crucial caveat: if you get your health insurance through a large, self-funded corporate employer, or if you are a state employee, these specific state-level mandates might not apply to your coverage, as those plans are governed by different federal or state exemptions.

What It Means for Your Business

For Colorado employers who provide fully insured health plans to their teams, this mandate will slightly shift your benefits landscape. Because the state is requiring insurance carriers to cover non-opioid painkillers at parity with opioids, the cost of paying for those newer or specialized medications will eventually be baked into the premium rates you pay. An actuarial analysis conducted for this legislation estimated that the new parity requirements will increase overall health insurance premiums across various market segments by roughly 0.1 percent. It is a marginal increase, but one to factor into your long-term benefits budgeting and annual renewal negotiations.

If you run a business in the healthcare space—particularly surgical centers, dental practices, or physical therapy clinics—this change is a massive operational win. Your administrative and medical staff will spend significantly less time fighting with insurance companies over step therapy protocols or filing tedious appeals for non-opioid prescriptions. Providers will have the freedom to prescribe the most clinically appropriate pain management strategy without worrying that the patient will abandon the prescription at the pharmacy counter due to an unexpected, massive copay. This smoother workflow means faster pain relief for your patients and fewer uncompensated administrative hours for your back office.

One important carve-out for business owners to remember: this legislation only applies to insurance plans regulated by the Colorado Division of Insurance, along with state Medicaid programs. If your company uses a self-insured model (where you pay healthcare claims out of your own corporate funds rather than buying a fully insured policy), federal ERISA laws pre-empt these state mandates, meaning you are not strictly required to adopt these changes. However, you may want to discuss with your broker whether voluntarily adding non-opioid parity to your plan design makes sense to help protect your workforce from opioid dependency and speed up recovery times.

Follow the Money

Enforcing this new parity law comes with a very modest, almost invisible price tag for the state budget. The Department of Regulatory Agencies (DORA) will need to hire a fractional amount of staff time (about 0.2 FTE) to review insurance form, rate, and formulary filings to ensure companies are actually complying with the non-opioid rules. This will cost roughly $20,000 in the first year and $10,000 annually after that. These funds are simply diverted from the General Fund into the Division of Insurance Cash Fund, which is funded by existing premium taxes.

There is, however, one slight financial wildcard for the state. Under the federal Affordable Care Act, if a state mandates a new benefit for individual or small group plans that the federal government doesn't consider an 'essential health benefit,' the state must pay for the additional costs incurred by insurers—a process called state defrayal. If the federal Department of Health and Human Services determines this non-opioid parity qualifies for state defrayal, Colorado taxpayers could eventually be on the hook to reimburse insurers for those specific coverage costs. The exact estimates for that potential scenario aren't available yet, as it depends entirely on how federal regulators interpret the new rules.

Where This Bill Stands

SB26-006 is currently Signed Into Law. The latest official action came on 06/03/2026: Governor Signed.

That means the legislative process is complete and the bill is now law. The remaining questions are about implementation timing and how agencies, businesses, or local governments respond.